Delivery Order SPE2DB25D3202-SPE2DB25FTAQA
Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units). This firm fixed-price delivery order, valued at $4,321.91, represents a non-set-aside award issued through competitive procurement. The contract is set for ultimate completion on August 8, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. CAPLYTA...
- The Defense Logistics Agency awarded a delivery order valued at $2,384.16 to AmerisourceBergen Drug Corp for CAPLYTA (lumateperone) 21 mg capsules (quantity: 30) on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment of...
- The Defense Logistics Agency awarded a $11.89K delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 24, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $14,646.30 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with a completion deadline of June 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. CAPLYTA is a prescription antipsychotic medication used in the treatment of schizophrenia and bipolar depression, representing the type of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed-price contract valued at $16,991.12. This non-competitive delivery order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment...
- The Defense Logistics Agency awarded a $3,203.19 delivery order to AmerisourceBergen Drug Corp for CAPLYTA 42 MG capsules (30-count units) on August 28, 2025, with completion by August 29, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $3,210.29 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on July 18, 2025, with completion anticipated by July 21, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award to the prime contractor based in Conshohocken, Pennsylvania. CAPLYTA is an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract valued at $10,226.69. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a $11.82K delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of CAPLYTA 42 mg capsules (30-count packaging), with performance completion scheduled for April 30, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Caplyta 21 mg capsules (30-count units) with a ceiling value of $1,561.30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is valued at up to $999,999,999.00 through December 2026 and serves as a comprehensive...